Cargando…
Arsenic Trioxide and Resveratrol Show Synergistic Anti-Leukemia Activity and Neutralized Cardiotoxicity
Cardiotoxicity is an aggravating side effect of many clinical antineoplastic agents such as arsenic trioxide (As(2)O(3)), which is the first-line treatment for acute promyelocytic leukemia (APL). Clinically, drug combination strategies are widely applied for complex disease management. Here, an opti...
Autores principales: | Fan, Yuhua, Chen, Meng, Meng, Jia, Yu, Lei, Tu, Yingfeng, Wan, Lin, Fang, Kun, Zhu, Wenliang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4140836/ https://www.ncbi.nlm.nih.gov/pubmed/25144547 http://dx.doi.org/10.1371/journal.pone.0105890 |
Ejemplares similares
-
The Protective Role of Resveratrol against Arsenic Trioxide-Induced Cardiotoxicity
por: Zhang, Weiqian, et al.
Publicado: (2013) -
Resveratrol and Arsenic Trioxide Act Synergistically to Kill Tumor Cells In Vitro and In Vivo
por: Zhao, Xiao-Yan, et al.
Publicado: (2014) -
In silico mechanisms of arsenic trioxide-induced cardiotoxicity
por: Li, Yacong, et al.
Publicado: (2022) -
Modulation of Cellular Response to Arsenic Trioxide
Toxicity by Resveratrol
por: Mondal, Bodhisattwa, et al.
Publicado: (2018) -
Ameliorative effects and mechanism of crocetin in arsenic trioxide-induced cardiotoxicity in rats
por: Zhao, Zhifeng, et al.
Publicado: (2020)